An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209548
Company: NOVAST LABS

Products on ANDA 209548

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LO-MALMOREDE	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209548

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/11/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 209548

LO-MALMOREDE

TABLET;ORAL-28; 0.035MG;1MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	No	AB	204703	MYLAN LABS LTD
KELNOR	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	No	AB	076785	BARR
LO-MALMOREDE	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	No	AB	209548	NOVAST LABS

Top